Skip to main content

Alert

Due to a lapse in appropriations, the NRC has ceased normal operations. However, excepted and exempted activities necessary to maintain critical health and safety functions—as well as essential progress on designated critical activities, including those specified in Executive Order 14300—will continue, consistent with the OMB-Approved NRC Lapse Plan.

Navigation

Spotlight

Frequently Asked Questions About Drug and Urine Specimen Validity Testing

This section provides the NRC staff's answers to the following questions related to drug and urine specimen validity testing, as it relates to fitness-for-duty:

With regard to the drug and alcohol testing provisions, does a descriptive summary document for the 2008 FFD rule exist?

The Federal Register notice for the Part 26 final rule (73 FR 16966), dated March 31, 2008, includes a summary and detailed descriptions of the changes to the drug and alcohol testing requirements. Section VI, page 16997 of the Federal Register Notice contains a "Section-by-Section Analysis of Substantive Changes" from the former rule provisions.

To top of page

Is a licensee testing facility required to include the quality control samples specified in 10 CFR 26.137(e)(6)(i)–(v) in at least one analytical run each quarter or for each analytical run?

10 CFR 26.137(e)(6)(i)-(v) describes the quality control samples that must be included in each analytical runof testing performed at a licensee testing facility.

To top of page

Page Last Reviewed/Updated Tuesday, March 10, 2020

Page Last Reviewed/Updated Tuesday, March 10, 2020